2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methoxybenzonitrile, 95.0%, 10g

5-Methoxyisoindolin-1-one, 95.0%, 250mg

METHYL 4-(1H-PYRROL-1-YL)BENZOATE, 95.0%, 1g

2-[(E)-2-(2-bromophenyl)vinyl]quinolin-8-ol, 95.0%, 1g

2-[2-(2-methyl-1H-imidazol-1-yl)ethyl]piperidine dihydrochloride hydrate, 95.0%, 5g

4-ethyl-5-[1-(4-ethylphenoxy)ethyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

5-Bromo-2-cyano-3-nitropyridine, 98.0%, 50g

2-Nitrobenzaldehyde, min. 98%, for synthesis, 250 g, plastic packaging.

4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one, 95+%, 250mg

3-Methyl-3H-imidazole-4-carbaldehyde, 97.0%, 1g

5-Bromo-3-methyl-pyridine-2-carboxylic acid, 95.0%, 100g

5-Bromo-2-chlorobenzaldehyde, 98.0%, 1kg

1-BOC-4-(2-Bromophenyl)piperidine, 97.0%, 5g